Cancer Research UK profiles AI-assisted blood test research for lung cancer detection
Professor Caroline Dive's group is investigating whether machine-learning analysis of blood samples could complement existing approaches to early lung cancer detection.
Cancer Research UK has published a feature on research led by Professor Caroline Dive at the Cancer Research UK Manchester Institute, exploring whether artificial-intelligence analysis of blood-based samples could improve early detection of lung cancer.
The work centres on liquid biopsy — the detection of tumour-derived material such as circulating tumour DNA or circulating tumour cells in blood — combined with machine-learning models trained to identify signals associated with early-stage disease. Lung cancer remains the leading cause of cancer death in the UK, and earlier detection is widely regarded as the most effective lever for improving outcomes.
The Cancer Research UK piece describes the scientific rationale and ongoing research programme rather than a completed clinical study. No peer-reviewed trial results are cited in the coverage. The research is at an exploratory stage; published guidance on lung cancer screening in the UK reflects the current evidence base from established imaging-based programmes, not liquid biopsy. This is an account of active research directions and should be read as such by all audiences.
Sources
Read the original reporting — these are the public sources this summary draws from.
-
Primary source Cancer Research UK · 2026-11-17Can AI help spot early signs of lung cancer in the blood?